Gunnar F. Kaufmann Oncternal Therapeutics, Inc. (ONCT) insider trading activity

ONCT Quotes by TradingView

Gunnar F. Kaufmann is Chief Scientific Officer of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 94,726 shares of ONCT, which is worth approximately $719,917. The most recent transaction as insider was on Jun 14, 2023, when has been sold 3,000 shares (Common Stock) at a price of $0.36 per share, resulting in proceeds of $1,080. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.7K
0% 3M change
0% 12M change
Total Value Held $719,917

Gunnar F. Kaufmann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Open market or private purchase
$1,080 $0.36 p/Share
3,000 Added 3.07%
94,726 Common Stock
Jun 12 2023
BUY
Open market or private purchase
$8,750 $0.35 p/Share
25,000 Added 21.42%
91,726 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$6,391 $1.02 p/Share
6,266 Reduced 8.58%
66,726 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
43,125 Added 37.14%
72,992 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
29,867 Added 50.0%
29,867 Common Stock
GFK

Gunnar F. Kaufmann

Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on ONCT

Follow Oncternal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONCT shares.

Notify only if

Insider Trading

Get notified when an Oncternal Therapeutics, Inc. insider buys or sells ONCT shares.

Notify only if

News

Receive news related to Oncternal Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ONCT